BIO

BIOME AUST FPO [BIO]
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complementary medicines in Australia and internationally. The company provides probiotics as live biotherapeutic products under the Activated Probiotics brand, and nutraceutical and complementary medicines under the Activated Therapeutics brand. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.
Consumer Defensive · ASX Small Cap
$0.2550 +2.0%

Updated 21 Jul 2026 · Signals refresh every scan

Get alerts when BIO triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track BIO — Free

Active Signals

Bullish Signals

  • Stochastic is deep in oversold territory — bounce conditions forming
  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Cash positive / operating cashflow positive
  • Low P/S ratio (2.6x)
  • Strong revenue growth (+40%)
  • Piotroski F-Score strong (8/9, low-confidence approx)
  • Post-earnings drift: positive surprise (SUE +10)
  • Near 52-week low (13% of range)
  • Small-cap ($20-100M)
  • Substantial holder(s) ceased (1)
  • CANSLIM C: Strong EPS growth (172% QoQ)
  • Strong return on equity (18%)
  • Sentiment is mixed — no strong consensus either way
  • Earnings are trending the right way — 2 consecutive improvements
  • Revenue growing at +40% — the top line is moving in the right direction
  • The bigger volume days are the up days — volume-weighted momentum is positive (1.06%/day)
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 47% over the past year
Ask Scout AI about BIO
"What's driving BIO today?" "How does BIO compare to peers?" "Key risks for BIO?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

MEDIUM FY26 Trading Update
NONE Change of Director's Interest Notice
NONE Change of Director's Interest Notice
NONE Change of Director's Interest Notice
HIGH Ceasing to be a substantial holder

Recent ASX Announcements

2026-06-30 FY26 Trading Update PRICE SENSITIVE
2026-06-25 Change of Director's Interest Notice
2026-06-12 Change of Director's Interest Notice
2026-06-12 Ceasing to be a substantial holder
2026-06-10 Change of Director's Interest Notice

Key Metrics

$58.1M
Market Cap
307K
Avg Volume
0.9x
Vol Ratio
$0.20 — $0.61
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
18.1%
ROE
4.4%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSpassEPS Growth: 172%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 64%
LLeader vs LaggardlaggardRS: -6
IInstitutional SponsorshipweakInst: 1%
MMarket DirectionneutralNeutral

Sector: Consumer Defensive

38 tickers in this sector

View all Consumer Defensive signals →Browse all ASX tickers A–Z →
Related Tickers
CCO -33.3%WOA -10.0%AHF -7.7%GNC +4.2%SVL -3.8%
Compare:BIO vs CCOBIO vs WOABIO vs AHF
Scout Pro — Deeper Analysis for BIO
Try Pro free for 30 days
Share this analysis

Track BIO and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required